Flecainide

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Flecainide and local guidelines before prescribing.

Class Ic antiarrhythmic

Mechanism

Class Ic sodium-channel blocker.

Uses

Paroxysmal AF (pill-in-pocket or maintenance) and SVT in structurally normal hearts.

Dosing

Side effects

Dizziness, visual disturbance, proarrhythmia, heart failure.

Interactions

Amiodarone, digoxin, beta-blockers, fluoxetine raise levels or effect.

Contraindications and cautions

Structural heart disease, post-MI, heart failure, Brugada syndrome

Monitoring

ECG (QRS), levels

Pregnancy and breastfeeding

Use if essential

Renal and hepatic impairment

Reduce dose in renal impairment

Overdose and reversal

Supportive; sodium bicarbonate

Special advice

Contraindicated after MI or in structural heart disease (CAST trial); give with AV nodal blocker in AF.

More from the textbook: uses, cautions and other points
Where it is discussed in the book